You just read:

Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension

News provided by

Cardiome Pharma Corp.

Jul 03, 2017, 08:00 ET